• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT TRABECULAR MICRO-BYPASS; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT TRABECULAR MICRO-BYPASS; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number GTS100L
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 10/30/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The stent was not implanted in the proper location, but may remain in the patient's eye therefore the surgery date was indicated in the implant date field.The device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were non-conformities found to be related to the reported event.A review of the device labeling was completed.Malpositioned stent is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.Based on the information received, the root cause of the reported event was due to operational context (experience with the device).Mfr# reference: (b)(4).
 
Event or Problem Description
It was initially reported that during a left eye cataract plus trabecular micro bypass stent procedure, the surgeon was unable to properly implant the stent in the right position (in the trabecular meshwork).Per report, surgical technique and experience with device contributed to the reported event.A back-up device was used to complete the procedure.There was no patient injury and there was no surgical or medical intervention required.Additional information was requested and the surgeon reported that after implantation attempt, the stent could not be located.It is unknown if the device remains in the patient's eye as the surgeon could not locate it.Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT TRABECULAR MICRO-BYPASS
Common Device Name
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
MDR Report Key9497111
Report Number2032546-2019-00155
Device Sequence Number209217
Product Code OGO
UDI-Device Identifier00853704002012
UDI-Public0100853704002012
Combination Product (Y/N)Y
Initial Reporter CountryKS
PMA/510(K) Number
P080030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/19/2019
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberGTS100L
Device Catalogue NumberGTS100L
Device Lot Number120951
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/02/2019
Initial Report FDA Received Date12/19/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Date Report Sent to FDA01/01/2005
-
-